Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"

Ralf Weiskirchen

doi:10.3390/cells11152403

Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"

Cells. 2022 Aug 4;11(15):2403. doi: 10.3390/cells11152403.

Author

Ralf Weiskirchen¹

Affiliation

¹ Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany.

Abstract

Hepatic fibrosis is a common type of liver disease that is attracting increasing attention of basic scientists and clinicians worldwide [...].

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Extracellular Matrix / pathology
Hepatic Stellate Cells* / pathology
Humans
Liver Cirrhosis / pathology
Liver Diseases* / pathology

Grants and funding

The laboratory of the author receives funding from the German Research Foundation (grants WE2554/13-1, WE2554/15-1, and WE2554/17-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.